193 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Building on our leadership positions in oncology, hematology and cardiovascular disease and growing our presence in immunology and neuroscience Launching … Nominees possess these qualities: Strategic Thinking Sound Business Judgment Integrity & Ethics Leadership
9 Continued Commitment to our Compensation
8-K
EX-99.2
yvuse51
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
5vrnx2yn
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
gbktmr 1if
8 Jan 24
Regulation FD Disclosure
10:29am
SC TO-C
EX-99.5
zsrhed69g503ranoa0
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
82ptk2a2f tsxkw
26 Dec 23
Information about tender offer
4:22pm
424B5
ofm2tfa 9rl1
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
xclsc
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.2
q36 950d8igjrk9el8qd
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
u76p u9fl
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
bovezk pra2pbgsho35
10 Oct 23
Additional proxy materials by non-management
6:48am
DEFA14A
rl1 4z6ehitw2nkz
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
8pzvxcz hmqp
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm